Physician

Richard W Parkinson, M.D.

According to 2025 Medicare claims, Richard Parkinson, M.D. (NPI: 1891801346) practices dermatology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. Parkinson uses personal NPI as billing NPI and primary practice location at 84604-7746.

Parkinson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 986 traditional Medicare patients, billed 14,027 HCPCS/CPT codes, and received $418,694 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 237 prescription claims across 128 beneficiaries totaling $15,346 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 24 records totaling $487. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $104,439 and ending at $15,346. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$209K$419K2015 Medicare payment: $293,642 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $360,874 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $292,554 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $341,949 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $356,677 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $374,405 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $389,793 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $376,217 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $410,690 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $418,694 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158265,544$293,642
20168826,536$360,874
20178245,526$292,554
201886711,846$341,949
20198918,566$356,677
20207798,637$374,405
20218658,797$389,793
202292311,173$376,217
20231,00310,819$410,690
202498614,027$418,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$67K$134K2015 Drug cost: $104,439 (USD; Tot_Drug_Cst)2016 Drug cost: $38,912 (USD; Tot_Drug_Cst)2017 Drug cost: $39,727 (USD; Tot_Drug_Cst)2018 Drug cost: $84,289 (USD; Tot_Drug_Cst)2019 Drug cost: $12,047 (USD; Tot_Drug_Cst)2020 Drug cost: $134,007 (USD; Tot_Drug_Cst)2021 Drug cost: $20,077 (USD; Tot_Drug_Cst)2022 Drug cost: $12,552 (USD; Tot_Drug_Cst)2023 Drug cost: $92,254 (USD; Tot_Drug_Cst)2024 Drug cost: $15,346 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201566181$104,439
201661121$38,912
201759127$39,727
201860122$84,289
2019114217$12,047
2020109220$134,007
202178172$20,077
202273140$12,552
2023100206$92,254
2024128237$15,346

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth333418$51
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7561,221$50
88305Pathology examination of tissue using a microscope, intermediate complexity403764$47
17000Destruction of precancer skin growth, 1 growth6891,077$31
17003Destruction of precancer skin growth, 2-14 growths6164,853$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole24700$1,783
MinoxidilMinoxidil453,790$909
FluorouracilFluorouracil11350$817
Clobetasol PropionateClobetasol Propionate18412$655
Triamcinolone AcetonideTriamcinolone Acetonide35862$341

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$487ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard W. Parkinson, M.D.?

Tedicare shows public-source Medicare data for Richard W. Parkinson, M.D. (NPI 1891801346), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard W. Parkinson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard W. Parkinson, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Richard W. Parkinson, M.D. have Open Payments data?

Richard W. Parkinson, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.